Results of a prospective Randomized trial on MMF-Therapy with or without cyclosporine - Withdrawal in chronic allograft nephropathy.

被引：0
|
作者：
Suwelack, BM [1 ]
Gerhardt, U [1 ]
Hohage, H [1 ]
机构：
[1] Univ Munster, Med Klin & Poliklin D, D-4400 Munster, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649A / 649A
页数：1
相关论文
共 50 条
  • [1] Effect of cyclosporine withdrawal on osteopontin expression and macrophage infiltration in established chronic cyclosporine nephropathy.
    Yang, CW
    Li, C
    Park, CW
    Cha, JH
    Choi, BS
    Kim, YS
    Kim, J
    Bang, BK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 163A - 163A
  • [2] CONVERSION TO SIROLIMUS IN ADVANCED STAGES OF CHRONIC ALLOGRAFT NEPHROPATHY. A RANDOMIZED CLINICAL TRIAL.
    Ghafari, Ali
    Ghafari, Negar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2097 - 2097
  • [3] Impact of cyclosporine reduction with MMF:: A randomized trial in chronic allograft dysfunction.: The 'reference' study
    Frimat, L.
    Cassuto-Viguier, E.
    Charpentier, B.
    Noel, C.
    Provot, F.
    Rostaing, L.
    Glotz, D.
    Sraer, J. D.
    Bourbigot, B.
    Moulin, B.
    Lang, P.
    Ducloux, D.
    Pouteil-Noble, C.
    Girardot-Seguin, S.
    Kessler, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (11) : 2725 - 2734
  • [4] Impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
    Saunders, RN
    Bicknell, GR
    Nicholson, ML
    TRANSPLANTATION, 2003, 75 (06) : 772 - 780
  • [5] Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial
    Hazzan, Marc
    Buob, David
    Labalette, Myriam
    Provot, Francois
    Glowacki, Francois
    Hoffmann, Maxime
    Copin, Marie-Christine
    Noel, Christian
    TRANSPLANTATION, 2006, 82 (05) : 657 - 662
  • [6] Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: A Randomized controlled trial
    Meier, M
    Nitschke, M
    Weidtmann, B
    Jabs, WJ
    Wong, WC
    Suefke, S
    Steinhoff, J
    Fricke, L
    TRANSPLANTATION, 2006, 81 (07) : 1035 - 1040
  • [7] Chronic allograft nephropathy: Prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution
    McGrath, JS
    Shehata, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2193 - 2195
  • [8] Is the improvement of renal function in chronic allograft nephropathy, after MMF introduction, related to cyclosporine reduction?
    Lemos, FBC
    Ianhez, LE
    Pereira, BJ
    Sabbaga, E
    David-Neto, E
    TRANSPLANTATION, 1999, 67 (07) : S86 - S86
  • [9] Chronic allograft nephropathy: A prospective randomised trial of Cyclosporin reduction with or without rapamycin.
    Saunders, RN
    Carr, S
    Nicholson, ML
    TRANSPLANTATION, 2000, 69 (08) : S226 - S226
  • [10] Chronic allograft nephropathy: A prospective randomised trial of cyclosporin deduction with or without mycophenolate mofetil
    Jain, S
    Metcalfe, M
    White, SA
    Furness, PN
    Nicholson, ML
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2165 - 2166
12345